Datalai (cetuximab biosimilar) - Sichuan Kelun Pharma
Jiataile (sacituzumab tirumotecan) - Merck (MSD)
Sertaly (trastuzumab botidotin) - Sichuan Kelun Pharma
tagitanlimab (HBM9167) - Harbour BioMed
EP0031 - Ellipses Pharma
https://www.prnewswire.com/news-releases/kelun-biotech-announces-2025-interim-results-302532141.html
 
Aug 18, 2025
 
Next